Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3NU5

Crystal Structure of HIV-1 Protease Mutant I50V with Antiviral Drug Amprenavir

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsAPS BEAMLINE 22-ID
Synchrotron siteAPS
Beamline22-ID
Temperature [K]100
Detector technologyCCD
Collection date2007-07-15
DetectorMARMOSAIC 300 mm CCD
Wavelength(s)1.0
Spacegroup nameP 21 21 2
Unit cell lengths57.953, 86.011, 46.209
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution10.000 - 1.290
R-factor0.1528
Rwork0.153
R-free0.19280
Structure solution methodMOLECULAR REPLACEMENT
Starting model (for MR)2qci
RMSD bond length0.012
RMSD bond angle0.030
Data reduction softwareHKL-2000
Data scaling softwareHKL-2000
Phasing softwarePHASER
Refinement softwareSHELXL-97
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]48.0601.340
High resolution limit [Å]1.2901.290
Rmerge0.0700.402
<I/σ(I)>2.3
Completeness [%]93.970.4
Redundancy4.52.1
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, HANGING DROP5.4298Crystal was grown by the hanging-drop vapor-diffusion method at room temperature, from a 3.5 mg/ml protein solution at pH 5.4 with 1M NaCl, 0.2M NaOAc. The inhibitor was mixed with protease in a ratio 10:1, VAPOR DIFFUSION, HANGING DROP, temperature 298K

238268

PDB entries from 2025-07-02

PDB statisticsPDBj update infoContact PDBjnumon